Boris Jordan Says In First Two Weeks Since Removed Cannabis From Narcotic List Seen Five-Fold Increase In Patients Approaching Telemedicine Platforms; Curaleaf Seeing 70% Increase In Order In First Weeks; 50% Increase In Second Week
Portfolio Pulse from Benzinga Newsdesk
Boris Jordan reported a significant increase in patient interest in cannabis following its removal from the narcotic list, with telemedicine platforms experiencing a five-fold increase in patient inquiries. Curaleaf (CURLF) has seen a 70% increase in orders in the first weeks and a 50% increase in the second week.
April 16, 2024 | 6:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Curaleaf has experienced a significant increase in orders following the removal of cannabis from the narcotic list, with a 70% increase initially and a 50% increase in the following week.
The removal of cannabis from the narcotic list has directly impacted Curaleaf's business, leading to a substantial increase in orders. This indicates a positive market response and potential revenue growth for Curaleaf, making it a significant event for investors.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
The article does not provide specific details on MSOS's performance following the deregulation of cannabis, but the overall sector growth implies potential positive impacts.
While the article does not mention MSOS directly in the context of the deregulation impact, the overall increase in patient interest and order volumes for cannabis products suggests a positive environment for cannabis-related ETFs like MSOS.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50